Insider · CIK 0000830588
Summit Partners L P
owner
Files at KVYO (Klaviyo, Inc.), LFST (LifeStance Health Group, Inc.), SBDS (Solo Brands, Inc.). First filing Nov 18, 2024, latest Sep 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $921M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
KVYO: Klaviyo, Inc.
KVYOOct 9, 2026 · close 17.32
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
LFST: LifeStance Health Group, Inc.
LFSTOct 9, 2026 · close 12.42
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 72Notable | Klaviyo, Inc. | $127M 4,000,000 shares | -100% | +36% from low-33% from high | |
| 72Notable | Klaviyo, Inc. | $29M 975,000 shares | -100% | +29% from low-36% from high | |
| 57Moderate | LifeStance Health Group, Inc. | $43M 8,407,643 shares | -20% | +43% from low-34% from high | |
| 72Notable | Klaviyo, Inc. | $195M 6,500,000 shares | -93% | +29% from low-36% from high | |
| 72Notable | Klaviyo, Inc. | $133M 4,000,000 shares | -100% | +42% from low-29% from high | |
| 72Notable | Klaviyo, Inc. | $132M 4,000,000 shares | -100% | +41% from low-30% from high | |
| 72Notable | Klaviyo, Inc. | $65M 2,000,000 shares | -100% | - | |
| 72Notable | Klaviyo, Inc. | $82M 2,100,000 shares | -100% | - | |
| 72Notable | Klaviyo, Inc. | $114M 3,153,293 shares | -90% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | SBDS Solo Brands, Inc. | CConversion Class A Common Stock, $0.001 par value per shareindirect: See Footnotes | +354,189 | - | - | 1,100,870 | Jan 5, 2026 |
| Jan 1, 2026 | SBDS Solo Brands, Inc. | JOther Class B Common Stock, $0.001 par value per shareindirect: See Footnotes | -354,189 | - | - | 0 | Jan 5, 2026 |
| Jan 1, 2026 | SBDS Solo Brands, Inc. | CConversion Common Unitsderivativeindirect: See Footnotes | -354,189 | $0.00 | $0 | 0 | Jan 5, 2026 |
| Sep 8, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnotes | +4,000,000 | - | - | 4,000,000 | Sep 10, 2025 |
| Sep 8, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -4,000,000 | $31.87 | $127M | 0 | Sep 10, 2025 |
| Sep 8, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnotes | +4,000,000 | $0.00 | $0 | 18,852,778 | Sep 10, 2025 |
| Aug 25, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +975,000 | - | - | 975,000 | Aug 27, 2025 |
| Aug 25, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnote | -975,000 | $30.01 | $29M | 0 | Aug 27, 2025 |
| Aug 25, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +975,000 | $0.00 | $0 | 22,852,778 | Aug 27, 2025 |
| Aug 21, 2025 | KVYO Klaviyo, Inc. | JOther Series A Common Stock, par value $0.001 per shareindirect: See footnote | -500,000 | $0.00 | $0 | 0 | Aug 22, 2025 |
| Aug 18, 2025 | LFST LifeStance Health Group, Inc. | SOpen-market sale Common Stock | -8,407,643 | $5.07 | $43M | 33,524,715 | Aug 20, 2025 |
| Aug 13, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +7,000,000 | - | - | 7,000,000 | Aug 15, 2025 |
| Aug 13, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -6,500,000 | $30.01 | $195M | 500,000 | Aug 15, 2025 |
| Aug 13, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +7,000,000 | $0.00 | $0 | 23,827,778 | Aug 15, 2025 |
| Jun 4, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +4,000,000 | - | - | 4,000,000 | Jun 5, 2025 |
| Jun 4, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -4,000,000 | $33.35 | $133M | 0 | Jun 5, 2025 |
| Jun 4, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +4,000,000 | $0.00 | $0 | 30,827,778 | Jun 5, 2025 |
| May 19, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +4,000,000 | - | - | 4,000,000 | May 20, 2025 |
| May 19, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -4,000,000 | $33.00 | $132M | 0 | May 20, 2025 |
| May 19, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +4,000,000 | $0.00 | $0 | 34,827,778 | May 20, 2025 |
| Mar 14, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +2,000,000 | - | - | 2,000,000 | Mar 17, 2025 |
| Mar 14, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -2,000,000 | $32.44 | $65M | 0 | Mar 17, 2025 |
| Mar 14, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +2,000,000 | $0.00 | $0 | 38,827,778 | Mar 17, 2025 |
| Dec 9, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +2,100,000 | - | - | 2,100,000 | Dec 11, 2024 |
| Dec 9, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -2,100,000 | $39.15 | $82M | 0 | Dec 11, 2024 |
| Dec 9, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +2,100,000 | $0.00 | $0 | 40,827,778 | Dec 11, 2024 |
| Nov 25, 2024 | KVYO Klaviyo, Inc. | JOther Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -346,707 | $0.00 | $0 | 0 | Nov 25, 2024 |
| Nov 14, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock, par value $0.001 per shareindirect: See footnote | +3,500,000 | - | - | 3,500,000 | Nov 18, 2024 |
| Nov 14, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock, par value $0.001 per shareindirect: See footnotes | -3,153,293 | $36.20 | $114M | 346,707 | Nov 18, 2024 |
| Nov 14, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stock, par value $0.001 per sharederivativeindirect: See footnote | +3,500,000 | $0.00 | $0 | 42,927,778 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.